Detalhe da pesquisa
1.
Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at Diagnosis.
Clin Gastroenterol Hepatol
; 21(11): 2928-2937.e12, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36787834
2.
Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
Gastroenterology
; 161(5): 1540-1551, 2021 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34293299
3.
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
Gastroenterology
; 159(1): 96-104, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32165208
4.
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.
Scand J Gastroenterol
; 52(10): 1086-1092, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28622097
5.
Serologic antibodies in relation to outcome in postoperative Crohn's disease.
J Gastroenterol Hepatol
; 32(6): 1195-1203, 2017 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-27976801
6.
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.
Gut
; 65(2): 249-55, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25670812
7.
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
Clin Gastroenterol Hepatol
; 13(6): 1103-10, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25478919
8.
A Novel 8-Predictors Signature to Predict Complicated Disease Course in Pediatric-onset Crohn's Disease: A Population-based Study.
Inflamm Bowel Dis
; 29(11): 1793-1804, 2023 11 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37266570
9.
Immunogenicity to infliximab is associated with HLA-DRB1.
Gut
; 64(8): 1344-5, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25876612
10.
Performance Characteristics of a Clinical Decision Support Tool for Disease Complications in Crohn's Disease.
Crohns Colitis 360
; 3(4): otab074, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36777269
11.
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.
Contemp Clin Trials Commun
; 14: 100345, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30989149
12.
Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease.
J Crohns Colitis
; 12(6): 653-661, 2018 May 25.
Artigo
Inglês
| MEDLINE | ID: mdl-29385469
13.
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
J Crohns Colitis
; 9(12): 1120-6, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26351386
14.
Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status.
PLoS One
; 9(8): e103551, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25090459
15.
Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients.
Inflamm Bowel Dis
; 19(6): 1139-48, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23518807
16.
Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior.
Inflamm Bowel Dis
; 17(12): 2488-96, 2011 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-21391291